Your Bridge to New Markets
Ewopharma (ewopharma.com) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Other brands, in the 42nd percentile of 11297 Healthcare brands.
Ewopharma is a Riga-based pharmaceutical services company that provides market access and medical marketing support to pharmaceutical firms seeking to expand into Central Eastern Europe and Switzerland. Drawing on decades of healthcare industry experience, the company helps clients bring Rx, OTC, and consumer health products to these markets. Ewopharma positions itself as a trusted partner for international pharma companies navigating regional market entry and expansion.
| Brand Name | Ewopharma |
|---|---|
| Domain | ewopharma.com |
| Industry | Healthcare, Other |
| Founded | 2021 |
| Headquarters | Riga |
| Main Competitors | IQVIA (85/100), Alvogen (78/100), Stada Arzneimittel (88/100), KRKA (87/100), Zentiva (79/100), Egis Pharmaceuticals (74/100), Adamed Pharma (75/100) |
Moz Domain Authority 31/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "With decades of experience in the healthcare industry, we provide companies with access to the pharmaceutical market in Central Eastern Europe & Switzerland. Tailor-made medica…" (Meta description: 34 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: PHP, Nginx.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Ewopharma?", Claude could identify the brand as of October 2026. Ewopharma is a Swiss pharmaceutical company based in Zug that specializes in licensing, marketing, and distributing pharmaceutical and healthcare products, with a strong focus on Central, Eastern, and Southeastern European markets. It acts as a partner for other pharma manufactur Best known for Marketing and distributing pharmaceutical products across Central and Eastern Europe on behalf of partner companies.
When asked "Best brands similar to Ewopharma?", Claude would recommend Ewopharma as of October 2026. It's a recognizable mid-sized player in European pharma distribution, so it could come up if someone asks about regional pharma licensing or distribution partners.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ewopharma's main competitors in Healthcare: IQVIA (85/100), Alvogen (78/100), Stada Arzneimittel (88/100), KRKA (87/100), Zentiva (79/100).
Sources: Brand Analyzer scan
Ewopharma has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 19, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Ewopharma official site
Ewopharma was founded in 2021. Ewopharma operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Ewopharma is headquartered in Riga. Ewopharma operates in the Healthcare category.
Sources: Wikidata
Ewopharma offers market access services and tailor-made medical marketing support for pharmaceutical companies. Its services help pharma firms introduce and expand Rx (prescription), OTC (over-the-counter), and consumer health products into Central Eastern European and Swiss markets.
Sources: Ewopharma official site
Ewopharma scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Ewopharma official site
Ewopharma is a pharmaceutical services company headquartered in Riga, Latvia, that specializes in market access and medical marketing for pharmaceutical companies entering Central Eastern European and Swiss markets.
Sources: Ewopharma official site
Ewopharma helps pharmaceutical companies expand their international operations by providing tailor-made medical marketing and market access expertise, enabling them to introduce Rx, OTC, and consumer health products into Central Eastern Europe and Switzerland.
Sources: Ewopharma official site
Ewopharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Ewopharma official site
Ewopharma's services are used by pharmaceutical companies seeking to expand their Rx, OTC, and consumer health product portfolios into Central Eastern European and Swiss markets.
Sources: Ewopharma official site
Ewopharma is known for serving as a bridge between pharmaceutical companies and Central Eastern European and Swiss markets, offering decades of healthcare industry experience in market access and medical marketing services.
Sources: Ewopharma official site
Ewopharma scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ewopharma has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 31/100 and thin schema.org structured data. In a live check, Claude could already identify Ewopharma from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Ewopharma: Evolent (75/100), EVIDENT (75/100), Exemplar Health Care (75/100), Exhale Wellness (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.